These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management. Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582 [TBL] [Abstract][Full Text] [Related]
3. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719 [TBL] [Abstract][Full Text] [Related]
4. The editor's roundtable: the JUPITER trial--initial results and clinical implications. Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439 [No Abstract] [Full Text] [Related]
6. The significance of plasma high density lipoprotein cholesterol (hdlc). Gupta S; Rajagopal G Nepal Med Coll J; 2007 Sep; 9(3):212-4. PubMed ID: 18092443 [TBL] [Abstract][Full Text] [Related]
7. Shedding light on high-density lipoprotein cholesterol: the post-ILLUMINATE era. Lavie CJ; Milani RV J Am Coll Cardiol; 2008 Jan; 51(1):56-8. PubMed ID: 18174037 [No Abstract] [Full Text] [Related]
8. Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia. Kostapanos MS; Milionis HJ; Filippatos TD; Christogiannis LG; Bairaktari ET; Tselepis AD; Elisaf MS J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):5-13. PubMed ID: 19246334 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508 [TBL] [Abstract][Full Text] [Related]
10. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy. Alagona P Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805 [TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of atherosclerosis: a practitioner's guide for 2008. Lewis SJ Am J Med; 2009 Jan; 122(1 Suppl):S38-50. PubMed ID: 19110087 [TBL] [Abstract][Full Text] [Related]
15. [Intervention study for elevating high density lipoprotein cholesterol level]. Kodama S; Sone H Nihon Rinsho; 2007 Jul; 65 Suppl 7():264-9. PubMed ID: 17824044 [No Abstract] [Full Text] [Related]
16. Evidence to support aggressive management of high-density lipoprotein cholesterol: implications of recent imaging trials. Taylor AJ Am J Cardiol; 2008 Apr; 101(8A):36B-43B. PubMed ID: 18375240 [TBL] [Abstract][Full Text] [Related]
17. Achieving cholesterol goals. Current and future drug therapies. Jones PH Postgrad Med; 2003 Aug; 114(2 Suppl):14-21. PubMed ID: 19667635 [TBL] [Abstract][Full Text] [Related]
18. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins? Goumas GS Angiology; 2009; 60(1):93-8. PubMed ID: 19019838 [TBL] [Abstract][Full Text] [Related]
19. The editor's roundtable: Acute decompensated heart failure. Friedewald VE; Gheorghiade M; Yancy CW; Young JB; Roberts WC Am J Cardiol; 2007 Jun; 99(11):1560-7. PubMed ID: 17531581 [No Abstract] [Full Text] [Related]